Braxia Scientific Awarded Government of Canada Funding to Complete First of its Kind Ketamine Clinical Trial for Bipolar Depression

[In The News]

Fully funded by the Canadian Institute of Health Research (CIHR), this multi-site clinical trial will take place at Toronto's University Health Network (UHN) and Braxia's CRTCE Research Clinic Largest study of its kind with IV Ketamine to be conducted in people living with bipolar...

View the full article